[A Case of Curative Resection Following TNT for Locally Advanced Rectal Cancer with Liver Metastasis]. 2023

Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
Dept. of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University.

The standard treatment of locally advanced rectal cancer is preoperative chemoradiotherapy(CRT)in Europe and the United States, while that is surgical excision and lateral pelvic lymph node dissection followed by adjuvant chemotherapy in Japan. Recently, total neoadjuvant therapy(TNT), which combines neoadjuvant chemotherapy and preoperative CRT, have been popular. We performed curative excision for initially locally advanced rectal cancer with liver metastasis after TNT. A 61- year-old woman was diagnosed as having rectal cancer with liver metastasis and invasion of the uterus, vagina, bladder, and left ureter. The patient underwent 8 courses of FOLFOX plus bevacizumab, followed by radiotherapy, and totally pelvic excision for the primary tumor. Because of liver metastasis progression, hepatectomy was performed after 6 courses of FOLFIRI plus panitumumab. The patient has been cancer free for 20 months to date. TNT is considered to be an effective strategy for the treatment of large locally advanced rectal cancer.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D059248 Chemoradiotherapy Treatment that combines chemotherapy with radiotherapy. Concurrent Chemoradiotherapy,Concomitant Chemoradiotherapy,Concomitant Radiochemotherapy,Concurrent Radiochemotherapy,Radiochemotherapy,Synchronous Chemoradiotherapy,Chemoradiotherapies,Chemoradiotherapies, Concomitant,Chemoradiotherapies, Concurrent,Chemoradiotherapies, Synchronous,Chemoradiotherapy, Concomitant,Chemoradiotherapy, Concurrent,Chemoradiotherapy, Synchronous,Concomitant Chemoradiotherapies,Concomitant Radiochemotherapies,Concurrent Chemoradiotherapies,Concurrent Radiochemotherapies,Radiochemotherapies,Radiochemotherapies, Concomitant,Radiochemotherapies, Concurrent,Radiochemotherapy, Concomitant,Radiochemotherapy, Concurrent,Synchronous Chemoradiotherapies

Related Publications

Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
March 2019, Gan to kagaku ryoho. Cancer & chemotherapy,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
December 2022, Gan to kagaku ryoho. Cancer & chemotherapy,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
November 2017, Gan to kagaku ryoho. Cancer & chemotherapy,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
January 2021, Case reports in gastroenterology,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
November 2004, Techniques in coloproctology,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
February 2006, Diseases of the colon and rectum,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
December 2021, Gan to kagaku ryoho. Cancer & chemotherapy,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
September 2023, Journal of gastrointestinal cancer,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
November 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Taiki Nakashima, and Shinichiro Mori, and Kan Tanabe, and Kentaro Hokonohara, and Yoshiaki Kita, and Yota Kawasaki, and Ken Sasaki, and Takaaki Arigami, and Hiroshi Kurahara, and Takao Ohtsuka
June 2021, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland,
Copied contents to your clipboard!